Innovation Accelerator
Provide innovators and developers of innovative products access to MHRA scientific expertise, regulatory guidance and an enhanced advice and signposting service.
Documents
Details
The Innovation Accelerator service will help provide innovators access to MHRA scientific expertise and regulatory guidance, helping developers of innovative products (medicines, medical devices (including software) and blood components for transfusion) connect more dynamically with an enhanced advice and signposting service.
The Innovation Accelerator functions bring together the Innovation Office, the Regulatory Advice Service for Regenerative Medicines (RASRM), Regulatory Science and horizon scanning. It also supports the delivery of the Innovative Licensing and Access Pathway (ILAP).
Updates to this page
Published 15 July 2022Last updated 17 January 2023 + show all updates
-
Added link to 'Horizon Scanning Case Study: What is an Actionable Horizon Scanning Signal (AHSS)?'
-
Added link to 'Horizon Scanning Case Study: Guiding principles that can inform the development of Good Machine Learning Practice'
-
A link to the recently published Horizon Scanning Case Study: Developing standards for Adeno-associated virus gene therapies has been included as an example.
-
First published.